世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米のDNAシーケンシング市場予測 2019-2027年

NORTH AMERICA DNA SEQUENCING MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2019年1月US$1,250
シングルユーザライセンス(印刷不可PDF)
103

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは北米のDNAシーケンシング市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The revenue generated by the North American DNA sequencing market is expected to catapult from $XX million to $XX million over the forecast period of 2019-2027, by exhibiting a CAGR of 17.44%. The region is expected to dominate the global scene, as compared to other regional markets. The future of medicine will be data-driven and focused on creating personalized medicines for each patient based on their molecular profile, that is going to drive the uptake of DNA sequencing technology in the upcoming years in the North America Region.

MARKET INSIGHTS

A high incidence of chronic diseases like diabetes and cancer is prevalent in this region, which is acting as a major driver for market growth. The U.S market leads this region, driven by favorable government initiatives and huge public and private funding. The Canadian market is expected to rise with the highest CAGR for the forecast period. The increasing application area of personalized medicine within this country is expected to influence its DNA sequencing market significantly. Also, the government of Canada will be supporting the implementation of genomics research in plant protection and food safety regulation to further improve species identification for early detection of plant pests and mislabeled fish and seafood; which is going to open new doors for opportunities for the DNA sequencing market in the country.

COMPETITIVE INSIGHTS

Companies like Agilent Technologies Inc, Thermo Fisher Scientifi Inc, Ubiquity Wafergen Bio-Systems Inc, Adaptive Biotechnologies Inc, Asuragen Inc, Genomics Inc, Cell Microsystems Inc, Appistry Inc, Roche Diagnostics, Illumina, Spiral Genetics Inc and Pacific Biosciences are actively engaged in this region.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. RISING USE OF PERSONALIZED MEDICINES
3.2.2. GROWTH IN SEQUENCING SERVICES
3.2.3. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES HOLDS THE LARGEST MARKET SHARE IN TERMS OF END USER
3.2.4. SEQUENCING BY SYNTHESIS IS THE WIDELY USED DNA SEQUENCING TECHNOLOGY
3.2.5. BIOMARKER IS THE MOST POPULAR DNA SEQUENCING APPLICATION
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. GROWING BREEDERS REQUIREMENT FOR THE ANIMALS & PLANTS REPRODUCTION
4.1.2. DEVELOPING TECHNOLOGY AND APPLIED MARKETS
4.1.3. INCREASING RESEARCH AND DEVELOPMENT IN DNA SEQUENCING MARKET
4.1.4. INCREASING PREVALENCE OF CANCER CASES
4.1.5. ENTRY OF NEW MARKET PLAYERS
4.1.6. INCREASING CONFERENCES AND WORKSHOPS RELATED TO DNA SEQUENCING MARKET
4.1.7. CONTINUING DECLINE IN SEQUENCING COSTS
4.1.8. GROWTH IN LIQUID BIOPSY APPLICATIONS
4.1.9. INCREASING PERSONALIZED THERAPIES
4.1.10. SURGE IN GENOME MAPPING PROGRAMS
4.2. MARKET RESTRAINTS
4.2.1. ACCURACY AND STANDARDIZATION CONCERNS IN DIAGNOSTIC TESTING
4.2.2. LACK OF SKILLED PROFESSIONALS
4.3. MARKET OPPORTUNITIES
4.3.1. INFLUENCE OF PERSONALIZED MEDICINE & BIOMARKER DISCOVERY
4.3.2. INCREASING GROWTH OF THE Y CHROMOSOME TESTING MARKET
4.3.3. ADVANCEMENT IN NGS (NEXT GENERATION SEQUENCING)
4.4. MARKET CHALLENGES
4.4.1. FRONT AND BACK-END CHALLENGES
4.4.2. LIMITATIONS IN BIOINFORMATICS
4.4.3. SOCIAL AND ETHICAL ISSUES
5. MARKET BY END USER
5.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
5.2. HOSPITALS & CLINICS
5.3. PHARMACEUTICAL
5.4. BIOTECHNOLOGY COMPANIES
5.5. OTHER END-USERS
6. MARKET BY TECHNOLOGY
6.1. SEQUENCING BY SYNTHESIS
6.2. ION SEMICONDUCTOR SEQUENCING
6.3. SEQUENCING BY LIGATION (SBL)
6.4. PYROSEQUENCING
6.5. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
6.6. CHAIN TERMINATION SEQUENCING
6.7. NANOPORE SEQUENCING
6.8. OTHER TECHNOLOGIES
7. MARKET BY APPLICATION
7.1. DIAGNOSTICS
7.2. DRUG DISCOVERY
7.3. BIOMARKER DISCOVERY
7.4. PERSONALIZED MEDICINE
7.5. AGRICULTURE & ANIMAL RESEARCH
7.6. REPRODUCTIVE HEALTH
7.7. FORENSICS
7.8. OTHER APPLICATIONS
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
8.1.3. BARGAINING POWER OF BUYER
8.1.4. BARGAINING POWER OF SUPPLIER
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. VALUE CHAIN ANALYSIS
8.3. KEY BUYING CRITERIA
8.4. STRATEGIC CONCLUSIONS
8.5. DNA SEQUENCING TIMELINE
8.6. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. THE UNITED STATES (US)
9.1.2. CANADA
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. COMPANY PROFILES
10.2.1. ABBOTT LABORATORIES.
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT PORTFOLIO
10.2.1.3. SCOT ANALYSIS
10.2.1.4. STRATEGIC INITIATIVES
10.2.2. ADAPTIVE BIOTECHNOLOGIES, INC
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. SCOT ANALYSIS
10.2.2.3. PRODUCT PORTFOLIO
10.2.3. AGILENT TECHNOLOGIES, INC.
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. SCOT ANALYSIS
10.2.3.3. PRODUCT PORTFOLIO
10.2.4. APPISTRY, INC.
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. SCOT ANALYSIS
10.2.4.3. PRODUCT PORTFOLIO
10.2.5. ASURAGEN, INC.
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. SCOT ANALYSIS
10.2.5.3. PRODUCT PORTFOLIO
10.2.6. BGI
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. SCOT ANALYSIS
10.2.6.3. PRODUCT PORTFOLIO
10.2.7. CELL MICROSYSTEMS, INC.
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. SCOT ANALYSIS
10.2.8. F. HOFFMANN-LA ROCHE LTD
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT PORTFOLIO
10.2.8.3. SCOT ANALYSIS
10.2.8.4. STRATEGIC INITIATIVES
10.2.9. ILLUMINA
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. SCOT ANALYSIS
10.2.9.3. PRODUCT PORTFOLIO
10.2.10. PACIFIC BIOSCIENCES
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. SCOT ANALYSIS
10.2.10.3. PRODUCT PORTFOLIO
10.2.10.4. STRATEGIC INITIATIVES
10.2.11. ROCHE DIAGNOSTICS
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. SCOT ANALYSIS
10.2.11.3. PRODUCT PORTFOLIO
10.2.12. SPIRAL GENETICS, INC.
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. SCOT ANALYSIS
10.2.12.3. PRODUCT PORTFOLIO
10.2.13. THERMO FISHER SCIENTIFIC, INC.
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. SCOT ANALYSIS
10.2.13.3. PRODUCT PORTFOLIO
10.2.14. UBIQUITY GENOMICS, INC.
10.2.14.1. COMPANY OVERVIEW
10.2.14.2. SCOT ANALYSIS
10.2.14.3. PRODUCT PORTFOLIO
10.2.15. WAFERGEN BIO-SYSTEMS, INC (MERGED WITH TAKARA BIO)
10.2.15.1. COMPANY OVERVIEW
10.2.15.2. SCOT ANALYSIS
10.2.15.3. PRODUCT PORTFOLIO
10.2.16. ZS GENETICS, INC.
10.2.16.1. COMPANY OVERVIEW
10.2.16.2. PRODUCT PORTFOLIO
10.2.16.3. STRATEGIC INITIATIVES

LIST OF TABLES
TABLE 1 NORTH AMERICA DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
TABLE 2 ESTIMATED NEW CASES AND DEATHS DUE TO CANCER 2018
TABLE 3 WORKSHOPS AND CONFERENCES RELATED TO DNA OR NEXT GENERATION SEQUENCING
TABLE 4 NORTH AMERICA DNA SEQUENCING MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA HOSPITALS & CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA PHARMACEUTICAL MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA BIOTECHNOLOGY COMPANIES MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA OTHER END-USER 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA DNA SEQUENCING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 11 SBS PARAMETERS AND DESCRIPTION
TABLE 12 NORTH AMERICA SEQUENCING BY SYNTHESIS MARKET 2019-2027 ($ MILLION)
TABLE 13 ION SEMICONDUCTOR SEQUENCING PARAMETERS (ION TORRENT SEQUENCING)
TABLE 14 NORTH AMERICA ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
TABLE 15 SBL (SEQUENCING BY LITIGATION) PARAMETERS (SOLID SEQUENCING)
TABLE 16 NORTH AMERICA SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
TABLE 17 ADVANTAGES AND DISADVANTAGES PYROSEQUENCING
TABLE 18 NORTH AMERICA PYROSEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 19 SINGLE MOLECULE REAL TIME SEQUENCING PARAMETERS (PACIFIC BIOSCIENCES)
TABLE 20 NORTH AMERICA SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA CHAIN TERMINATION SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA NANOPORE SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA OTHER TECHNOLOGIES MARKET 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA DNA SEQUENCING MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 25 FDA-APPROVED DRUGS ALONG WITH A COMPANION DIAGNOSTIC
TABLE 26 NORTH AMERICA DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 27 NORTH AMERICA DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 28 NORTH AMERICA BIOMARKER DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 29 NORTH AMERICA PERSONALIZED MEDICINE MARKET 2019-2027 ($ MILLION)
TABLE 30 NORTH AMERICA AGRICULTURE & ANIMAL RESEARCH MARKET 2019-2027 ($ MILLION)
TABLE 31 NORTH AMERICA REPRODUCTIVE HEALTH MARKET 2019-2027 ($ MILLION)
TABLE 32 NORTH AMERICA FORENSICS MARKET 2019-2027 ($ MILLION)
TABLE 33 NORTH AMERICA OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 34 NORTH AMERICA DNA SEQUENCING MARKET BY COUNTRY 2019-2027($ MILLION)
TABLE 35 STATISTICS OF CANCER CASES IN U.S.

LIST OF FIGURES
FIGURE 1 NORTH AMERICA DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
FIGURE 2 LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3 NORTH AMERICA DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA DNA SEQUENCING MARKET BY PHARMACEUTICAL 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA DNA SEQUENCING MARKET BY BIOTECHNOLOGY COMPANIES 2019-2027 ($ MILLION)
FIGURE 7 BIOTECHNOLOGICAL TOOLS USED FOR CROP PROTECTION
FIGURE 8 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA DNA SEQUENCING MARKET BY PYROSEQUENCING 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA DNA SEQUENCING MARKET BY CHAIN TERMINATION SEQUENCING 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA DNA SEQUENCING MARKET BY NANOPORE SEQUENCING 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA DNA SEQUENCING MARKET BY DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA DNA SEQUENCING MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA DNA SEQUENCING MARKET BY REPRODUCTIVE HEALTH 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA DNA SEQUENCING MARKET BY FORENSICS 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 25 NUMBER OF CANCER CASES AND DEATHS IN U.S. FOR 2016
FIGURE 26 PREVALENCE OF DIABETES IN CANADA IN 2015 & 2025 (MILLION)
FIGURE 27 THE UNITED STATES DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 28 CANADA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 29 DNA SEQUENCING MARKET SHARE ANALYSIS 2017 (%)

List of Tables

LIST OF TABLES
TABLE 1 NORTH AMERICA DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
TABLE 2 ESTIMATED NEW CASES AND DEATHS DUE TO CANCER 2018
TABLE 3 WORKSHOPS AND CONFERENCES RELATED TO DNA OR NEXT GENERATION SEQUENCING
TABLE 4 NORTH AMERICA DNA SEQUENCING MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA HOSPITALS & CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA PHARMACEUTICAL MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA BIOTECHNOLOGY COMPANIES MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA OTHER END-USER 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA DNA SEQUENCING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 11 SBS PARAMETERS AND DESCRIPTION
TABLE 12 NORTH AMERICA SEQUENCING BY SYNTHESIS MARKET 2019-2027 ($ MILLION)
TABLE 13 ION SEMICONDUCTOR SEQUENCING PARAMETERS (ION TORRENT SEQUENCING)
TABLE 14 NORTH AMERICA ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
TABLE 15 SBL (SEQUENCING BY LITIGATION) PARAMETERS (SOLID SEQUENCING)
TABLE 16 NORTH AMERICA SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
TABLE 17 ADVANTAGES AND DISADVANTAGES PYROSEQUENCING
TABLE 18 NORTH AMERICA PYROSEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 19 SINGLE MOLECULE REAL TIME SEQUENCING PARAMETERS (PACIFIC BIOSCIENCES)
TABLE 20 NORTH AMERICA SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA CHAIN TERMINATION SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA NANOPORE SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA OTHER TECHNOLOGIES MARKET 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA DNA SEQUENCING MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 25 FDA-APPROVED DRUGS ALONG WITH A COMPANION DIAGNOSTIC
TABLE 26 NORTH AMERICA DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 27 NORTH AMERICA DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 28 NORTH AMERICA BIOMARKER DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 29 NORTH AMERICA PERSONALIZED MEDICINE MARKET 2019-2027 ($ MILLION)
TABLE 30 NORTH AMERICA AGRICULTURE & ANIMAL RESEARCH MARKET 2019-2027 ($ MILLION)
TABLE 31 NORTH AMERICA REPRODUCTIVE HEALTH MARKET 2019-2027 ($ MILLION)
TABLE 32 NORTH AMERICA FORENSICS MARKET 2019-2027 ($ MILLION)
TABLE 33 NORTH AMERICA OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 34 NORTH AMERICA DNA SEQUENCING MARKET BY COUNTRY 2019-2027($ MILLION)
TABLE 35 STATISTICS OF CANCER CASES IN U.S.

List of Figures

LIST OF FIGURES
FIGURE 1 NORTH AMERICA DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
FIGURE 2 LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3 NORTH AMERICA DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA DNA SEQUENCING MARKET BY PHARMACEUTICAL 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA DNA SEQUENCING MARKET BY BIOTECHNOLOGY COMPANIES 2019-2027 ($ MILLION)
FIGURE 7 BIOTECHNOLOGICAL TOOLS USED FOR CROP PROTECTION
FIGURE 8 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA DNA SEQUENCING MARKET BY PYROSEQUENCING 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA DNA SEQUENCING MARKET BY CHAIN TERMINATION SEQUENCING 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA DNA SEQUENCING MARKET BY NANOPORE SEQUENCING 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA DNA SEQUENCING MARKET BY DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA DNA SEQUENCING MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA DNA SEQUENCING MARKET BY REPRODUCTIVE HEALTH 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA DNA SEQUENCING MARKET BY FORENSICS 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 25 NUMBER OF CANCER CASES AND DEATHS IN U.S. FOR 2016
FIGURE 26 PREVALENCE OF DIABETES IN CANADA IN 2015 & 2025 (MILLION)
FIGURE 27 THE UNITED STATES DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 28 CANADA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 29 DNA SEQUENCING MARKET SHARE ANALYSIS 2017 (%)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る